Yu Wang1, Karey Shumansky2, Don D Sin2, S F Paul Man2, Loubna Akhabir2, John E Connett3, Nicholas R Anthonisen4, Peter D Paré2, Andrew J Sandford2, Jian-Qing He5. 1. Department of Respiratory and Critical Medicine, West China Hospital of Sichuan University Chengdu, Sichuan Province, China. 2. Centre for Heart Lung Innovation, University of British Columbia and St. Paul's Hospital Vancouver, BC, Canada. 3. Division of Biostatistics, School of Public Health, University of Minnesota Minneapolis, MN, USA. 4. Faculty of Medicine, University of Manitoba Winnipeg, MB, Canada. 5. Department of Respiratory and Critical Medicine, West China Hospital of Sichuan University Chengdu, Sichuan Province, China ; Centre for Heart Lung Innovation, University of British Columbia and St. Paul's Hospital Vancouver, BC, Canada.
Abstract
OBJECTIVE: We reported association of haplotypes formed by IL-1b (IL1B)-511C/T (rs16944) and a variable number of tandem repeats (rs2234663) in intron 3 of IL-1 receptor antagonist (IL1RN) with rate of lung function decline in smoking-induced COPD. The aim of current study was to further investigate this association. METHODS: We genotyped an additional 19 polymorphisms in IL1 cluster (including IL1A, IL1B and IL1RN) in non-Hispanic whites who had the fastest (n = 268) and the slowest (n = 292) decline of FEV1% predicted in the same study. We also analyzed the association of all 21 polymorphisms with serum CRP levels. RESULTS: None of 21 polymorphisms showed significant association with rate of decline of lung function or CRP levels after adjusting for multiple comparisons. Before adjusting for multiple comparisons, only IL1RN_19327 (rs315949) showed significant association with lung function decline (P = 0.03, additive model). The frequencies of genotypes containing the IL1RN_19327A allele were 71.9% and 62.2%, respectively in the fast and slow decline groups (P = 0.02, odds ratio = 1.6, 95% confidence interval = 1.1-2.3); the IL1B_5200 (rs1143633) and rs2234663 in IL1RN were associated with serum CRP levels (P=0.04 and 0.03, respectively). CONCLUSIONS: No single marker was significantly associated with either rate of lung function decline or serum CRP levels.
OBJECTIVE: We reported association of haplotypes formed by IL-1b (IL1B)-511C/T (rs16944) and a variable number of tandem repeats (rs2234663) in intron 3 of IL-1 receptor antagonist (IL1RN) with rate of lung function decline in smoking-induced COPD. The aim of current study was to further investigate this association. METHODS: We genotyped an additional 19 polymorphisms in IL1 cluster (including IL1A, IL1B and IL1RN) in non-Hispanic whites who had the fastest (n = 268) and the slowest (n = 292) decline of FEV1% predicted in the same study. We also analyzed the association of all 21 polymorphisms with serum CRP levels. RESULTS: None of 21 polymorphisms showed significant association with rate of decline of lung function or CRP levels after adjusting for multiple comparisons. Before adjusting for multiple comparisons, only IL1RN_19327 (rs315949) showed significant association with lung function decline (P = 0.03, additive model). The frequencies of genotypes containing the IL1RN_19327A allele were 71.9% and 62.2%, respectively in the fast and slow decline groups (P = 0.02, odds ratio = 1.6, 95% confidence interval = 1.1-2.3); the IL1B_5200 (rs1143633) and rs2234663 in IL1RN were associated with serum CRP levels (P=0.04 and 0.03, respectively). CONCLUSIONS: No single marker was significantly associated with either rate of lung function decline or serum CRP levels.
Entities:
Keywords:
C-reactive protein; Chronic obstructive pulmonary disease (COPD); IL1 gene cluster; forced expiratory volume in one second (FEV1); genetic polymorphism; lung function decline
Authors: Christopher S Carlson; Michael A Eberle; Mark J Rieder; Qian Yi; Leonid Kruglyak; Deborah A Nickerson Journal: Am J Hum Genet Date: 2003-12-15 Impact factor: 11.025
Authors: Doron Aronson; Inon Roterman; Mordechay Yigla; Arthur Kerner; Ophir Avizohar; Ron Sella; Peter Bartha; Yishai Levy; Walter Markiewicz Journal: Am J Respir Crit Care Med Date: 2006-06-15 Impact factor: 21.405
Authors: Arun B Josyula; Margaret Kurzius-Spencer; Sally R Littau; Berran Yucesoy; James Fleming; Jefferey L Burgess Journal: J Occup Environ Med Date: 2007-03 Impact factor: 2.162
Authors: Clinio Alves De Souza; Argos Queiroz Alves De Souza; Maria do Socorro Queiroz Alves De Souza; José Alberto Dias Leite; Maíra Silva De Morais; Sílvia Helena Barem Rabenhorst Journal: Acta Orthop Date: 2017-07-06 Impact factor: 3.717